122856-26-2 (2H-吡喃-2-酮,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-氨基乙基)-10-环己基-3,6-二羟基-4-(膦酰基)-1,7,9-癸三烯-1-基]-5-乙基-5,6-二氢-(5S,6S)-,2H-Pyran-2-one,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-aminoethyl)-10-cyclohexyl-3,6-dihydroxy-4-(phosphonooxy)-1,7,9-decatrien-1-yl]-5-ethyl-5,6-dihydro-,(5S,6S)-)

CAS号:
122856-26-2
中文名称:
2H-吡喃-2-酮,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-氨基乙基)-10-环己基-3,6-二羟基-4-(膦酰基)-1,7,9-癸三烯-1-基]-5-乙基-5,6-二氢-(5S,6S)-
英文名称:
2H-Pyran-2-one,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-aminoethyl)-10-cyclohexyl-3,6-dihydroxy-4-(phosphonooxy)-1,7,9-decatrien-1-yl]-5-ethyl-5,6-dihydro-,(5S,6S)-
分子式:
C25H40NO8P
分子量:
513.560769081116

2H-吡喃-2-酮,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-氨基乙基)-10-环己基-3,6-二羟基-4-(膦酰基)-1,7,9-癸三烯-1-基]-5-乙基-5,6-二氢-(5S,6S)-(122856-26-2)名称与标识符

名称

英文别名:
2H-Pyran-2-one,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-aminoethyl)-10-cyclohexyl-3,6-dihydroxy-4-(phosphonooxy)-1,7,9-decatrien-1-yl]-5-ethyl-5,6-dihydro-,(5S,6S)-;(4E,6E)-1-[(2E)-1-(2-aminoethyl)-3-(3-ethyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-hydroxyprop-2-en-1-yl]-7-cyclohexyl-3-hydroxyhepta-4,6-dien-1-yl dihydrogen phosphate;2H-Pyran-2-one,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-aminoethyl)-10-cyclohexyl-3,6-dihydroxy-4-(phosphonooxy)-1,7,9-decatrien-1-yl]-5-e;Phoslactomycin B;6-[3-(2-Aminoethyl)-10-cyclohexyl-3,6-dihydroxy-4-phosphonooxy-1,7,9-decatrienyl]-5-ethyl-5,6-dihydro-2H-pyran-2-one;6-[[3-(2-Aminoethyl)-10-cyclohexyl-3,6-dihydroxy-4-(phosphonooxy)deca-1,7,9-trien]-1-yl]-5-ethyl-5,6-dihydro-2H-pyran-2-one;2H-Pyran-2-one, 6-(3-(2-aminoethyl)-10-cyclohexyl-3,6-dihydroxy-4-(phosphonooxy)-1,7,9-decatrienyl)-5-ethyl-5,6-dihydro-;[(1E,7E,9E)-3-(2-aminoethyl)-10-cyclohexyl-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxydeca-1,7,9-trien-4-yl] dihydrogen phosphate;122856-26-2;[(1E,3R,4R,6R,7Z,9Z)-3-(2-aminoethyl)-10-cyclohexyl-1-[(2S,3S)-3-ethyl-6-oxo-2,3-dihydropyran-2-yl]-3,6-dihydroxydeca-1,7,9-trien-4-yl] dihydrogen phosphate;Q27149191;CHEBI:80042;DTXSID401100396;

标识符

InChIKey:
GAIPQMSJLNWRGC-VYTJGNNZSA-N
Inchi:
1S/C25H40NO8P/c1-2-20-12-13-24(28)33-22(20)14-15-25(29,16-17-26)23(34-35(30,31)32)18-21(27)11-7-6-10-19-8-4-3-5-9-19/h6-7,10-15,19-23,27,29H,2-5,8-9,16-18,26H2,1H3,(H2,30,31,32)/b10-6+,11-7+,15-14+
SMILES:
P(=O)(O)(O)OC(CC(/C=C/C=C/C1CCCCC1)O)C(/C=C/C1C(C=CC(=O)O1)CC)(CCN)O

2H-吡喃-2-酮,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-氨基乙基)-10-环己基-3,6-二羟基-4-(膦酰基)-1,7,9-癸三烯-1-基]-5-乙基-5,6-二氢-(5S,6S)-(122856-26-2)物化性质

计算特性

  • 精确分子量 : 513.24915423g/mol
  • 氢键供体数量 : 5
  • 氢键受体数量 : 9
  • 可旋转化学键数量 : 13
  • 同位素质量 : 513.24915423g/mol
  • 重原子数量 : 35
  • 复杂度 : 829
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 5
  • 确定化学键立构中心数量 : 3
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -0.3
  • 拓扑分子极性表面积 : 160Ų

2H-吡喃-2-酮,6-[(1E,3R,4R,6R,7Z,9Z)-3-(2-氨基乙基)-10-环己基-3,6-二羟基-4-(膦酰基)-1,7,9-癸三烯-1-基]-5-乙基-5,6-二氢-(5S,6S)-(122856-26-2)相关文献